Inventor · disambiguated record
Madan M. Paidhungat
Also filed as: PAIDHUNGAT MADAN · PAIDHUNGAT MADAN M
13 granted patents·19 pending applications·121 citations·filing 2006–2024
92Inventor score
Top patents by PatentIndex Score
32 records- 0194US7794718B2Immunosuppressive polypeptides and nucleic acidsPERSEID THERAPEUTICS LLC·Filed 2008·Granted Sep 14, 2010·38 cites·19 claims
- 0293US8071095B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2010·Granted Dec 6, 2011·17 cites·19 claims
- 0390US11667687B2Masked activatable interferon constructsCYTOMX THERAPEUTICS INC·Filed 2022·Granted Jun 6, 2023·3 cites·30 claims
- 0490US8318176B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Nov 27, 2012·10 cites·8 claims
- 0590US8283447B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Oct 9, 2012·10 cites·8 claims
- 0690US8268587B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Sep 18, 2012·10 cites·48 claims
- 0787US8496935B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Jul 30, 2013·7 cites·27 claims
- 0887US8445230B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted May 21, 2013·7 cites·48 claims
- 0986US8491899B2Immunosuppressive polypeptides and nucleic acidsKARRER ERIK E·Filed 2011·Granted Jul 23, 2013·6 cites·21 claims
- 1084US7619067B2Evolved interferon-alpha polypeptidesMAXYGEN INC·Filed 2006·Granted Nov 17, 2009·12 cites·18 claims
- 1183US11365233B2Activatable cytokine constructs and related compositions and methodsCYTOMX THERAPEUTICS INC·Filed 2021·Granted Jun 21, 2022·1 cites·29 claims
- 1276US2025179141A1Activatable cytokine constructs and related compositions and methodsCYTOMX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1372US12091442B2Activatable cytokine constructs and related compositions and methodsCYTOMX THERAPEUTICS INC·Filed 2022·Granted Sep 17, 2024·0 cites·20 claims
- 1469US2025026801A1Activatable cytokine constructs and combination methodsCYTOMX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1566US2024124546A1Masked activatable cytokine constructs and related compositions and methodCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1663US2023192798A1Activatable cytokine constructs and combination methodsCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1761US2025333487A1Activatable dual-anchored masked molecules and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1860US2025215110A1Activatable multispecific molecules and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1958US2019270985A1Monoliths with attached recognition compounds, arrays thereof and uses thereofDICE MOLECULES SV LLC·Filed 2019·Application pending·0 cites
- 2058US2025230239A1Cd3-binding proteins and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2158US2023174995A1Activatable polypeptide complexCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2258US2023183382A1Activatable polypeptide complexCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2356US2025333539A1Activatable antigen-binding protein constructs and uses of the sameCYTOMX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2456US2024400630A1Activatable cytokine constructs and related compositions and methodsCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2555US2024398920A1Trimeric activatable cytokine constructs and related compositions and methodsCYTOMX THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2651US10358641B2Monoliths with attached recognition compounds, arrays thereof and uses thereofDICE MOLECULES SV LLC·Filed 2015·Granted Jul 23, 2019·0 cites·24 claims
- 2750US2021403594A1Epcam antibodies, activatable antibodies, and immunoconjugates, and uses thereofIMMUNOGEN INC·Filed 2019·Application pending·0 cites
- 2848US2018179517A9Monoliths with Attached Recognition Compounds, Arrays Thereof and Uses ThereofDICE MOLECULES SV LLC·Filed 2017·Application pending·0 cites
- 2947US2021324088A1Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereofCYTOMX THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3036US2012135912A1Polypeptide inhibitors of vla4PAIDHUNGAT MADAN M·Filed 2011·Application pending·0 cites
- 3133US2017348666A1Methods of routing, compositions and uses thereofDICE MOLECULES SV LLC·Filed 2017·Application pending·0 cites
- 3228US2015344872A1Methods of synthesis of oligonucleotide tagged combinatorial libraries and uses thereofDICE MOLECULES SV LLC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Madan M. Paidhungat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →